fda warning peptides bpc 157 not approved safety concerns panel narrowly backs unapproved peptide drugs – NBC4 Washington Exciting news for peptides coming

[1] [2] As of 20242025, retatrutide remains under clinical investigation and has not been approved by the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom, nor by the European Medicines Agency (EMA) or the US Food and Drug Administration (FDA) for routine clinical use

If you are interested in learning more, we welcome you to call the office at (407) 219-9682

Additional information Presented as an oral communication at the: XIth International Facial Nerve Symposium in Rome, 2009 and British Oculoplastic Surgery Society Annual Meeting 2010

So the documented 330 mcg dose is drawn to the 10-unit line